Consumers (Biologics)
![consumer talking to pharmacist](https://public4.pagefreezer.com:443/content/FDA/21-07-2024T13:05/https://www.fda.gov/files/styles/main_image_medium/public/recommending-an-overthecounter-remedy-picture-id537277550.jpg?itok=rwrpuQO0)
Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins
Blood & Blood Products
- Questions about Blood
- Have You Given Blood Lately?
- Keeping Blood Transfusions Safe: FDA's Multi-layered Protections for Donated Blood
Tissue & Tissue Products
- Cord Blood Banking - Information for Consumers
- Questions about Tissues
- Frequently Asked Questions About Tissue Transplants (Centers for Disease Control and Prevention)
Vaccines
- Vaccines for Children - A Guide for Parents and Caregivers
- Questions about Vaccines
- Vaccine Safety Questions and Answers
- Influenza Virus Vaccine Safety & Availability
- Thimerosal in Vaccines Questions and Answers
- Zostavax (Herpes Zoster Vaccine) Questions and Answers
Regenerative Medicine and Related Products
Guidance, Compliance & Regulatory Information
- Biologics Rules
- Biologics Guidances
- Biologics Post-Market Activities
- Compliance Actions (Biologics)
- Untitled Letters (CBER)
Safety & Availability
- Report a Problem to the Center for Biologics Evaluation & Research
- How to Report Product Problems and Complaints to the FDA
- Impact of Severe Weather Conditions on Biological Products
- Recalls (Biologics)
- CBER-Regulated Products: Shortages and Discontinuations
- Blood Safety & Availability
- Investigation of whether the acute hemolysis associated with Rho(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model
- Tissue Safety & Availability
- Vaccine Safety & Availability
Science & Research
Partnerships/Collaborations
Follow CBER
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Center for Biologics Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave WO71-3103
Silver Spring, MD 20993-0002
(800) 835-4709
(240) 402-8010
For Updates on Twitter, follow @fdacber